Archive of news published by the FAMHP
- 17.06.2022 - PRAC June 2022 –Update of COVID-19 vaccins and new safety information for Xalkori
- 08.12.2021 - PRAC December 2021 – Assessment of recent data on the known risk of myocarditis and pericarditis following vaccination with COVID-19 vaccines Comirnaty and Spikevax
- 19.11.2021 - Coronavirus: updated timelines for applications for COVID-19 clinical trials
- 09.11.2021 - PRAC November 2021: updates on COVID-19 vaccines and conclusion of safety signal for Imbruvica
- 13.10.2021 - PRAC October 2021 – Nomegestrol containing products and chlormadinone containing products and update on COVID-19 vaccines
- 02.09.2021 - Coronavirus: new version of Belgian directive for management of clinical trials during coronavirus pandemic
- 13.08.2021 - PRAC August 2021 – Recommendation and review of safety issues related to COVID-19 vaccines
- 23.06.2021 - Coronavirus: details of the renewed measures taken by the FAMHP to avoid medicine shortages
- 02.06.2021 - Coronavirus: EMA approves additional manufacturing capacity for Pfizer/BioNTech COVID-19 vaccine
- 11.05.2021 - Coronavirus: the FAMHP monitors stocks of medicines using a new tool
- 06.05.2021 - Coronavirus: weekly overview of 6 May 2021 on adverse reactions of COVID-19 vaccines
- 29.04.2021 - Coronavirus: weekly overview of 29 April 2021 on adverse reactions of COVID-19 vaccines
- 27.04.2021 - Coronavirus: weekly update of 27 April 2021 on vaccine deliveries and information on vaccination equipment
- 22.04.2021 - Coronavirus: weekly overview of 22 April 2021 on adverse reactions of COVID-19 vaccines
- 20.04.2021 - Coronavirus: weekly update of 20 April 2021 on vaccine deliveries and information on vaccination equipment
- 20.04.2021 - Coronavirus: COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets. EMA confirms overall benefit-risk remains positive
- 16.04.2021 - PRAC April 2021 – Conclusions and additional review on Vaxzevria (AstraZeneca’s COVID-19 vaccine), and new investigations on COVID-19 Vaccine Janssen
- 15.04.2021 - Coronavirus: weekly overview of 15 April 2021 on adverse reactions of COVID-19 vaccines
- 13.04.2021 - Coronavirus: weekly update of 13 April 2021 on vaccine deliveries and information on vaccination equipment
- 08.04.2021 - Coronavirus: weekly overview of 8 April 2021 on adverse reactions of COVID-19 vaccines
- 07.04.2021 - Coronavirus: EMA finds possible link between Vaxzevria (AstraZeneca) and very rare cases of unusual blood clots with low level of blood platelets
- 06.04.2021 - Coronavirus: weekly update of 6 April 2021 on vaccine deliveries and information on vaccination equipment
- 01.04.2021 - Coronavirus: weekly overview of 1 April 2021 on adverse reactions of COVID-19 vaccines
- 30.03.2021 - Coronavirus: weekly update of 30 March 2021 on vaccine deliveries and information on vaccination equipment
- 25.03.2021 - Coronavirus: weekly overview of 25 March 2021 on adverse reactions of COVID-19 vaccines
- 25.03.2021 - Flash VIG-news: recommendations for thrombocytopenia and coagulation disorders with COVID-19 Vaccine AstraZeneca
- 22.03.2021 - Coronavirus: EMA organises third public hearing on new COVID-19 vaccines
- 18.03.2021 - Coronavirus: weekly overview of 18 March 2021 on adverse reactions of COVID-19 vaccines
- 18.03.2021 - Coronavirus: benefits of COVID-19 Vaccine AstraZeneca still outweigh the risks despite possible link to rare blood clots with low blood platelets
- 16.03.2021 - Coronavirus: weekly update of 16 March 2021 on vaccine deliveries and information on vaccination equipment
- 16.03.2021 - Coronavirus: update on investigation of thromboembolic events with AstraZeneca’s COVID-19 vaccine
- 11.03.2021 - Coronavirus: currently no indication that AstraZeneca’s COVID-19 vaccine has caused thromboembolic events, review is ongoing at European level
- 11.03.2021 - Coronavirus: weekly overview of 11 March 2021 on adverse reactions of COVID-19 vaccines
- 11.03.2021 - Coronavirus: European Commission grants conditional marketing authorisation for Janssen's vaccine against COVID-19
- 11.03.2021 - Coronavirus: EMA gives positive opinion for Janssen vaccine
- 09.03.2021 - Coronavirus: weekly update of 9 March 2021 on vaccine deliveries and information on vaccination equipment
- 04.03.2021 - Coronavirus: weekly overview of 4 March 2021 on adverse reactions of COVID-19 vaccines
- 04.03.2021 - Coronavirus: EMA starts rolling review of the Sputnik V COVID-19 vaccine
- 02.03.2021 - Coronavirus: weekly update of 2 March 2021 on vaccine deliveries and information on vaccination equipment
- 26.02.2021 - Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
- 25.02.2021 - Coronavirus: weekly overview of 25 February 2021 on adverse reactions of COVID-19 vaccines
- 23.02.2021 - Coronavirus: weekly update of 23 February 2021 on vaccine deliveries and information on vaccination equipment
- 18.02.2021 - Coronavirus: weekly overview of 18 February 2021 on adverse reactions of COVID-19 vaccines
- 16.02.2021 - Coronavirus: weekly update of 16 February 2021 on vaccine deliveries and information on vaccination equipment
- 16.02.2021 - Coronavirus: EMA receives application for conditional marketing authorisation for Janssen vaccine
- 12.02.2021 - Coronavirus: EMA starts rolling review of CureVac vaccine against COVID-19
- 11.02.2021 - Coronavirus: weekly overview of 11 February 2021 on adverse reactions of COVID-19 vaccines
- 10.02.2021 - Coronavirus: swabs: compliance verification
- 09.02.2021 - Coronavirus: weekly update of 9 February 2021 on vaccine deliveries and information on vaccination equipment
- 04.02.2021 - Coronavirus: weekly overview of 4 February 2021 on adverse reactions of COVID-19 vaccines
- 02.02.2021 - Coronavirus: weekly update of 2 February 2021 on vaccine deliveries and information on vaccination equipment
- 01.02.2021 - Coronavirus: European Commission gives conditional marketing authorisation for AstraZeneca vaccine against COVID-19
- 01.02.2021 - Coronavirus: EMA gives positive opinion for AstraZeneca vaccine
- 28.01.2021 - Coronavirus: weekly overview of 28 January 2021 on adverse reactions of COVID-19 vaccines
- 26.01.2021 - Coronavirus: weekly update of vaccine deliveries and information on vaccination equipment
- 21.01.2021 - Coronavirus: weekly overview of 21 January 2021 on adverse reactions of COVID-19 vaccines
- 19.01.2021 - Coronavirus: weekly update of vaccine deliveries and information on vaccination equipment
- 14.01.2021 - Coronavirus: weekly overview of 14 January 2021 on adverse reactions of COVID-19 vaccines
- 12.01.2021 - Coronavirus: EMA receives application for conditional marketing authorisation for AstraZeneca vaccine
- 08.01.2021 - Coronavirus: sixth dose from vials of Comirnaty vaccine (Pfizer/BioNTech)
- 07.01.2021 - Coronavirus: weekly overview of 7 January 2021 on adverse reactions of COVID-19 vaccines
- 06.01.2021 - Coronavirus: European Commission gives conditional marketing authorisation for Moderna vaccine against COVID-19
- 06.01.2021 - Coronavirus: EMA gives positive opinion for Moderna vaccine
- 29.12.2020 - Coronavirus: EMA organises a second public meeting about the new COVID-19 vaccines
- 24.12.2020 - Coronavirus: new online form to report suspected adverse reactions to a COVID-19 vaccine
- 24.12.2020 - Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
- 23.12.2020 - Coronavirus: end of exceptional measures for surgical face masks
- 21.12.2020 - Coronavirus: European Commission gives conditional market authorisation for vaccine against COVID-19
- 21.12.2020 - Coronavirus: the EMA gives a first positive opinion for COVID-19 vaccine
- 02.12.2020 - Coronavirus: the Inter-Ministerial Conference on Public Health agrees on the European procurement procedure for Moderna vaccine candidate and finalizes COVID-19 vaccination strategy
- 01.12.2020 - Coronavirus: EMA receives first two applications for conditional marketing authorisation of COVID-19 vaccines
- 27.11.2020 - Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
- 25.11.2020 - Coronavirus: EMA organises public meeting on COVID-19 vaccines
- 24.11.2020 - Coronavirus: Belgium agrees on procurement of CureVac's vaccine candidate
- 18.11.2020 - Coronavirus: Belgium agrees on procurement of Pfizer/BioNTech vaccine candidate
- 16.11.2020 - The federal government and the federated entities work together to vaccinate at least 8 million Belgians
- 09.11.2020 - Coronavirus: the FAMHP again calls for rational use of oxygen
- 28.10.2020 - Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
- 19.10.2020 - Coronavirus: Belgium agrees on procurement of Janssen's (Johnson & Johnson) vaccine candidate
- 07.10.2020 - Coronavirus: EMA starts first rolling reviews of COVID-19 vaccines
- 06.10.2020 - Coronavirus – a new validation procedure for serological tests
- 28.09.2020 - Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
- 21.09.2020 - Coronavirus: at-home antibody tests are no longer banned, but the FAMHP warns against misinterpreting the result
- 07.09.2020 - Coronavirus - Consultation between the FAMHP and the clinical labs about the serological tests for COVID-19
- 28.08.2020 - Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
- 21.08.2020 - Coronavirus - Belgium joins Europe for the purchase of the vaccine candidate against COVID-19 from AstraZeneca
- 20.08.2020 - Coronavirus - Advisory committee on choice of COVID-19 vaccines treats first dossier
- 20.08.2020 - The COVID-19 serological tests bought by the government are reliable
- 06.08.2020 - Coronavirus: Evaluation of the use of saliva samples as an alternative to sampling via a deep nasal swab to detect SARS-CoV-2, the virus that causes COVID-19
- 30.07.2020 - Coronavirus: Derogation for COVID-19 clinical trials of medicinal products containing or consisting of genetically modified organisms
- 28.07.2020 - Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
- 13.07.2020 - Coronavirus: shorter deadlines for clinical trials
- 27.06.2020 - Coronavirus and the fight led by the FAMHP: the FAMHP is preparing for a potential pandemic resurgence
- 26.06.2020 - Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
- 26.06.2020 - Coronavirus and the fight led by the FAMHP: the FAMHP carries out hundreds of controls and inspections to ensure the compliance and safety of medicines and health products
- 25.06.2020 - Coronavirus and the fight led by the FAMHP: the FAMHP constantly monitors the safety of treatments
- 24.06.2020 - Coronavirus and the fight led by the FAMHP: solutions implemented by the FAMHP in the face of medical equipment shortages
- 24.06.2020 - Coronavirus: FAMHP adds dexamethasone to the list of medicinal products subject to controlled distribution measures
- 23.06.2020 - Coronavirus and the fight led by the FAMHP: the FAMHP facilitates and supports the development of COVID-19 treatments and vaccines
- 22.06.2020 - Coronavirus and the fight led by the FAMHP: rigorous work to ensure each patient receives the treatment they need
- 19.06.2020 - Coronavirus : first COVID-19 vaccine trial authorized in Belgium
- 12.06.2020 - Coronavirus: the FAMHP is allowing an extension of the payment deadlines expiring before 01.07.2020
- 03.06.2020 - Coronavirus: third version of the Alternative Test Protocol (ATP) for surgical face masks
- 29.05.2020 - Coronavirus: extension and relaxing of measures taken by the FAMHP to avoid medicinal product shortages
- 27.05.2020 - Coronavirus: hydroxychloroquine: off-label use strongly discouraged and new benefit-risk assessment for clinical trials
- 26.05.2020 - Coronavirus: newly updated guidelines for verifying the compliance and suitability of surgical face masks
- 25.05.2020 - Coronavirus: reminder of the risks of chloroquine and hydroxychloroquine
- 20.05.2020 - Coronavirus: recommendations for replacing closed suction systems
- 12.05.2020 - Coronavirus: updated guidelines for verifying the compliance and suitability of surgical face masks
- 11.05.2020 - Coronavirus: relaxation of paracetamol measures for pharmacists and patients
- 06.05.2020 - Coronavirus: updated Belgian directive for the reuse of surgical and FFP2/FFP3 face masks during the COVID-19 pandemic
- 04.05.2020 - Coronavirus: good practices when changing consumables used with COVID-19 patient ventilators
- 04.05.2020 - Coronavirus: European Medicines Agency recommends continued use of medicinal products for high blood pressure, heart and kidney disease
- 03.05.2020 - Coronavirus: national guideline for the management of clinical investigations for medical devices during the coronavirus pandemic
- 02.05.2020 - Coronavirus: guidelines for 3D printing of respiratory device accessories
- 30.04.2020 - Coronavirus: how should tests be made available in Belgium?
- 30.04.2020 - Coronavirus: new version of Belgian directive for management of clinical trials during coronavirus pandemic
- 29.04.2020 - Coronavirus: new version of Alternative Test Protocol (ATP) for surgical face masks
- 28.04.2020 - Coronavirus: extension of measures taken by FAMHP to avoid medicinal product shortages
- 24.04.2020 - Coronavirus: reminder of risk of serious adverse effects associated with chloroquine and hydroxychloroquine
- 24.04.2020 - Coronavirus: COVID-19 patients should also report adverse reactions
- 20.04.2020 - Coronavirus: delivery of medicinal products to ambulatory patients’ homes by the authorised hospital
- 17.04.2020 - Coronavirus: status of medicinal product stocks for hospitals
- 17.04.2020 - Coronavirus: joint statement from the FAMHP and the ABSYM/BVAS (Belgian association of unions for medical practitioners) responding to the concerns of healthcare professionals in the field
- 15.04.2020 - Coronavirus: the FAMHP continues to supply essential medicinal products for intensive care and provides hospitals with daily updates
- 14.04.2020 - Coronavirus: Alternative Test Protocol (ATP) for surgical face masks
- 14.04.2020 - Coronavirus: softening of measures concerning paracetamol
- 14.04.2020 - Flash VIG-news: risk of haemolysis associated with the use of hydroxychloroquine (PLAQUENIL) in the treatment of COVID-19
- 10.04.2020 - Coronavirus: measures taken by the FAMHP and relevant partners to continue to guarantee oxygen supplies
- 09.04.2020 - Coronavirus: circular for care institutions on the (outsourcing of the) manufacture and reprocessing of medical devices and their accessories
- 07.04.2020 - Coronavirus: Belgian directive for the reuse of surgical masks and FFP2/FFP3 masks in the context of the COVID-19 epidemic
- 01.04.2020 - Coronavirus: FAMHP measures to avoid medication shortages
- 01.04.2020 - Coronavirus: hydroxychloroquine, chloroquine and Kaletra (lopinavir & ritonavir) are subject to controlled distribution in Belgium to enhance monitoring of treatments
- 01.04.2020 - Flash VIG-news: pay attention to the elimination half-life of hydroxychloroquine and chloroquine and to the risks of drug interactions
- 30.03.2020 - Coronavirus: guidelines for checking the compliance and suitability of certain surgical face masks
- 25.03.2020 - Coronavirus: the FAMHP seizes postal packages containing counterfeit and other illegal medicinal products against COVID-19
- 25.03.2020 - Coronavirus: Belgian guideline for the management of clinical trials during the coronavirus pandemic
- 24.03.2020 - Coronavirus: what medicinal products are used in the fight against COVID-19?
- 21.03.2020 - Coronavirus: European guidelines for the management of clinical trials during the coronavirus pandemic
- 20.03.2020 - Coronavirus: ban on the sale of rapid diagnostic tests due to the risk of misinterpretation
- 19.03.2020 - Coronavirus: do not pointlessly stock up on medicinal products
- 18.03.2020 - Coronavirus: the FAMHP is taking measures to guarantee continuity of treatment for patients suffering from chronic illnesses
- 16.03.2020 - A working group (Task Force) should come up with immediate solutions to remedy the shortage of protective equipment and medical equipment on the Belgian market
- 16.03.2020 - Coronavirus: paracetamol remains the first choice for cases of fever and pain
- 16.03.2020 - Directive on the direct dispensing of medicinal products to patients in the context of clinical trials
- 16.03.2020 - Corona virus: first contact your general practitioner and/or pharmacist by phone if you suspect you have symptoms
- 14.03.2020 - COVID-19: electronic files submission
- 04.03.2020 - Coronavirus: no shortage in medication supply, FAMHP closely monitoring the situation
General information on www.info-coronavirus.be
Information for healthcare professionals via Sciensano